Literature DB >> 30690032

Epigenetics, cardiovascular disease, and cellular reprogramming.

Keith Al-Hasani1, Prabhu Mathiyalagan2, Assam El-Osta3.   

Abstract

Under the seeming disorder of "junk" sequences the last decade has seen developments in our understanding of non-coding RNA's (ncRNAs). It's a complex revised order and nowhere is this more relevant than in the developing heart whereby old rules have been set aside to make room for new ones. The development of the mammalian heart has been studied at the genetic and cellular level for several decades because these areas were considered ideal control points. As such, detailed mechanisms governing cell lineages are well described. Emerging evidence suggests a complex new order regulated by epigenetic mechanisms mark cardiac cell lineage. Indeed, molecular cardiologists are in the process of shedding light on the roles played by ncRNAs, nucleic acid methylation and histone/chromatin modifications in specific pathologies of the heart. The aim of this article is to discuss some of the recent advances in the field of cardiovascular epigenetics that are related to direct cell reprogramming and repair. As such, we explore ncRNAs as nodes regulating signaling networks and attempt to make sense of regulatory disorder by reinforcing the importance of epigenetic components in the developmental program.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30690032     DOI: 10.1016/j.yjmcc.2019.01.019

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

Review 1.  Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis.

Authors:  Irina V Bure; Marina V Nemtsova; Ekaterina B Kuznetsova
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

2.  High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling.

Authors:  Keith A Strand; Sizhao Lu; Marie F Mutryn; Linfeng Li; Qiong Zhou; Blake T Enyart; Austin J Jolly; Allison M Dubner; Karen S Moulton; Raphael A Nemenoff; Keith A Koch; Daniel V LaBarbera; Mary C M Weiser-Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-06-25       Impact factor: 8.311

Review 3.  Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity.

Authors:  Himani Kumari; Wan-Hong Huang; Michael W Y Chan
Journal:  Front Cardiovasc Med       Date:  2020-05-07

4.  Nitric Oxide as a Potential Adjuvant Therapeutic for Neuroblastoma: Effects of NO on Murine N2a Cells.

Authors:  Jenna L Gordon; Melissa M Reynolds; Mark A Brown
Journal:  Vet Sci       Date:  2020-04-23

5.  Epigenetic Factors of Disease.

Authors:  Ilham Alshiraihi; Mark A Brown
Journal:  Diseases       Date:  2019-06-14

6.  Epigenetics and expression of key genes associated with cardiac fibrosis: NLRP3, MMP2, MMP9, CCN2/CTGF and AGT.

Authors:  Sruti Chandra; Kenneth C Ehrlich; Michelle Lacey; Carl Baribault; Melanie Ehrlich
Journal:  Epigenomics       Date:  2021-02-04       Impact factor: 4.778

7.  Cell-specific epigenetic changes in atherosclerosis.

Authors:  Abdul Waheed Khan; Francesco Paneni; Karin A M Jandeleit-Dahm
Journal:  Clin Sci (Lond)       Date:  2021-05-14       Impact factor: 6.124

Review 8.  Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis.

Authors:  Ruo-Lan Li; Ling-Yu Wang; Shuqin Liu; Hu-Xinyue Duan; Qing Zhang; Ting Zhang; Wei Peng; Yongliang Huang; Chunjie Wu
Journal:  Front Nutr       Date:  2022-03-24

Review 9.  The epigenetics of diabetes, obesity, overweight and cardiovascular disease.

Authors:  Harem Othman Smail
Journal:  AIMS Genet       Date:  2019-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.